Navigation Links
Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
Date:10/18/2007

forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A, "Risk Factors" in the company's second quarter 2007 10-Q.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
2. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Immunomedics Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy
5. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
6. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
7. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
8. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
9. Sygnis Pharma AG announces date for presentation of clinical results
10. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
11. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Frost & Sullivan,s ... to speaking at the 2010 International Consumer ... January 9, 2010 in Las Vegas. ... of consumer-based digital health and wellness devices, ... http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch focuses on patient ...
(Date:12/16/2009)... Dec. 16 The Boards of Silence ... delighted to announce the merger of their businesses ... of RNAi (RNA interference). The enlarged company, ... RNAi discovery, development and delivery technologies, a broad ... portfolio of intellectual property. ,, The Directors ...
(Date:12/16/2009)... Dec. 16 Keryx Biopharmaceuticals, Inc. ... initiation of a Phase 3 registration clinical ... pathway inhibitor, in relapsed / refractory multiple ... Phase 3 Randomized Study to Assess the ... the Combination of Bortezomib (Velcade®) and Dexamethasone ...
Breaking Medicine Technology:Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7Abbott Cuts Use of Oil and Coal by 35 Percent 5108 1Abbott Cuts Use of Oil and Coal by 35 Percent 5108 2Abbott Cuts Use of Oil and Coal by 35 Percent 5108 3Urologists Radiologists Patients Benefit From New Clinical Prostate Visualization System 5105 1Urologists Radiologists Patients Benefit From New Clinical Prostate Visualization System 5105 2 2416 8 million grant awarded to develop platelet recovery treatments 58550 1 2416 8 million grant awarded to develop platelet recovery treatments 58550 2
(Date:12/16/2009)... owner of Supreme Ultimate Fitness in Boca Raton, ... his students in the new year. The difference with this ... own prize or against each other. They will be losing ... Society in Boca Raton, FL. ,, "For every ... February 28, 2010 I will donate $10 to the Tri ...
(Date:12/16/2009)... , , TUESDAY, Dec. 15 (HealthDay News) -- If that ... on your life that you just can,t wait to have ... you might want to wait at least six months before ... be even better. , The study found that when ... chances of the baby dying, being born prematurely, having birth ...
(Date:12/16/2009)... received a further 1.6 million Euro in capital funding to ... in order to meet the rapidly growing demand for this promising ... A/S that continue to own each about 50% of the company. ... ... Unisense FertiliTech A/S has received a further 1.6 million Euro ...
(Date:12/16/2009)... announce being presented with the Weatherhead 100 Upstart Award on December ... in Northeast Ohio and is a testament to hard work, commitment, ... ... (PRWEB) December 16, 2009 -- Request A Test, Ltd. ... Award on December 3, 2009. The Weatherhead 100 showcases the ...
(Date:12/16/2009)... will continue to offer free nationwide confidential legal consultations for ... effects such as: Birth Defects, Attempted Suicide, Suicide and Addiction ... free at 1-800-856-6405 or go to the firm’s website at ... form. , ... (PRWEB) December 16, ...
Breaking Medicine News(10 mins):Health News:Fitness Trainer Motivates Clients with Weight Loss to Help Raise Money for Animal Shelter 2Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free Legal Consultations For Users of Paxil 3
... May 29 Britannia members overwhelmingly endorse plans ... to create new super-mutual:- New business will be ... services, providing ethical alternative to banks- Strong strategic ... expected efficiency and revenue benefits of pounds Sterling ...
... WASHINGTON, May 29 The following advisory is being ... http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ) WHAT: American ... June 4, 10 a.m. WHERE : National Press Club ... American Life League, Pharmacists for Life International, Pro-Life ...
... Beckman Coulter, Inc. (NYSE: BEC ), ... that simplify, automate, and innovate complex biomedical testing, ... president of strategy, will present at the Goldman ... at 11:00 a.m. (ET).(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )The ...
... Fla.--The vast majority of advanced colon cancer patients in ... of prescription drugs for managing chemotherapy side effects, such ... to reduce drug cost burdens after joining the clinical ... Dana-Farber Cancer Institute in Boston. Although few patients reported ...
... New mushrooms offer 100 percent of recommended daily Vitamin ... Through a truly collaborative research effort with the United ... been successful in replicating what happens in nature when ... light the same way humans do, by converting the ...
... and Long-Term Care to Youth with Special NeedsWASHINGTON, May 29 ... anniversary with the launch of Home at HSC , ... home environment for long-term patients age 6 months to 21 ... provide in a home, group home or typical long-term care ...
Other Medicine News:Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 2Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 3Health News:Britannia Members Back Super-Mutual Merger With the Co-Operative Financial Services 4Health News:The Pill Kills Women: Largest Protest Against Birth Control Pill 2Health News:1 in 10 advanced colon cancer patients worry about prescription drug costs 2Health News:Monterey Mushrooms Launches Vitamin D Enriched Sun Grill-A-Bella and White Mushrooms 2Health News:Home At HSC 2
... FLEXILOG antimony pH catheters are designed for patient ... ,All catheters are number marked at 5cm intervals ... than sixteen individual models are available spanning most ... or multi-use models with one or two sensors., ...
... catheter has two sensors and a black ... allowing optimal placement in relation to the ... esophageal pH monitoring. , ,Alpine's VersaFlex ... on the market (4.7 French), and are ...
... Slimline single-use pH catheters are efficient, ... and allow greater patient comfort during ... pH measurement systems have been designed ... allow an accurate room-temperature calibration. The ...
FLEXILOG accessory....
Medicine Products: